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Leiden, 19th of May 2017 
 
 
Dear Mr. Fouque, 
 
 
Please find enclosed the revised version of our manuscript “Metabolic Imaging of Fatty 
Kidney in Diabesity: Validation and Dietary Intervention”.  
 
We appreciate the constructive comments by the reviewers, which helped to improve 
our manuscript.  
 
All changes in the manuscript are highlighted. Please find attached point-to-point 
answers to the comments of the reviewers as well as the changes in the revised 
manuscript.  
 
If the manuscript Is accepted for publication, we would like to have Figure 5 printed in 
black and white and in colour online. 
 
We hope that the revised manuscript is acceptable for publication in NDT.  
 
 
On behalf of all authors, 
 
Yours sincerely, 
 
Jacqueline Jonker 
Paul de Heer 
Leiden University Medical Center 
Leiden, the Netherlands 
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Response to comments of the reviewer: 
We thank the reviewer for his/her comments that helped us to improve the manuscript. 
 
"De Heer et al. present a manuscript in which they report on non-invasive measurement 
of renal triglyceride content by 1H-MRS, and compare this with tissue analyses. The 
manuscript is well-written and the data are clearly presented. I have the following 
questions and suggestions:  
 
1) The authors have shown relatively strong associations between renal lipid 
accumulation quantified by MRS and enzymatic assays. However, this is not the same 
as good agreement between the two techniques. I suggest they provide Bland-Altman 
plots to address this 
 
In accordance with the comment of the reviewer, we added a Bland-Altman plot to 
Figure 2 to address this point. 
  
2) How do the authors explain the discrepancy between the effects on body weight gain 
and lipid accumulation (Fig 3a vs 3b/c)?  
 
We thank the reviewer for this relevant comment. Indeed, this is a very interesting 
observation. In insulin resistant states, like the pigs in the cafeteria + streptozocin group, 
there is an increase in lipolysis (because of the relative shortage of insulin), leading to 
redistribution of triglycerides from adipose tissue to the organs (ectopic fat). 
Furthermore, the increased inflammation may lead to additional triglyceride deposition 
in the organs and especially the kidney, beyond mere obesity.  
 
We added this to the discussion: 
`Interestingly, pigs in the cafeteria+STZ group, albeit that they had a lower baseline 
weight and equal increase in body weight during the study, did have increased renal 
triglyceride content compared to the controls. In diabetes, an increase in lipolysis and in 
inflammation might lead to additional triglyceride redistribution into organs beyond mere 
obesity and thus accentuate the findings (2) `. 
 
3) The fact that no significant differences between the groups were present for the 
MRS-based renal lipid measurements (despite n=15/group), although a trend was 
clearly present, suggests that some animals apparently displayed high lipid 
accumulation in their kidneys whereas other animals were very similar to controls. 
Could the authors provide additional data clarifying what could explain the inter-
individual variation within the groups?  
 
This is an interesting observation and there were indeed large inter-individual 
differences between the pigs. However we don’t think it is possible to draw any 
conclusions on the underlying mechanisms, as the groups consisted of 5 pigs per diet 
group. There seems to be a trend toward higher fructosamin levels (as a proxy for 
insulin resistance) in the pigs with the highest renal TG content, however this is not 
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statistically significant. Therefore, it is important to repeat these studies in-vivo with 
larger groups . 
 
4) What is the relationship between MRS findings and renal triglyceride accumulation 
quantified by the Oil Red O staining?  
 
The Pearson correlation between the renal triglyceride content measured by 1H-MRS 
and the lipids measured by Oil Red O staining is 0.67 (P=0.006). We did not include this 
comparison in our manuscript, as Oil Red O measures all lipids in the biopsy, while 1H-
MRS measures specifically triglycerides.  
  
5) How can the authors be sure that this is actually renal lipid accumulation, and not 
clearance we are looking at? From Figure 5 it seems that the majority of the lipids are 
present in vesicles within the tubuli. This makes the reviewer wonder whether fatty 
kidney is actually a pathophysiological phenomenon or rather a reflection of high-fat 
intake?" 
 
This is a very important remark indeed. We think both suggestions of the reviewer are 
true. Tubular uptake of non esterified fatty acids (NEFA) occurs proportional to 
glomerular albuminuria and the plasma NEFA concentration. Some of the NEFA 
undergo oxidation for formation of ATP for high energy processes, the rest is stored into 
lipid droplets as triglycerides (TG). As accounts for other organs (heart, muscle), a little 
TG storage will indeed not interfere with organ function. However, in animal studies, it 
has been shown that an excess in renal TG deposition can lead to tubulointerstitial 
injury. Furthermore the accumulation of TG also leads to an increase in renal 
gluconeogenesis and in type 2 diabetes, the kidney contributes to postprandial and 
fasting hyperglycemia. Therefore, the amount of renal TG accumulation depends on 
high fat intake and insulin sensitivity. 
(Refs: D'Agati VD et al. (2016) Obesity-related glomerulopathy: clinical and pathologic 
characteristics and pathogenesis. Nat Rev Nephrol Aug;12(8):453-71; de Vries et al. 
Ruggenenti P, Ruan XZ, et al (2014) Fatty kidney: emerging role of ectopic lipid in 
obesity-related renal disease. Lancet Diabetes Endocrinol 5:417-426). 
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Abstract  
 
Background 
Obesity and type 2 diabetes have not only been linked to fatty liver, but also to fatty kidney 
and chronic kidney disease. Since noninvasive tools are lacking to study fatty kidney in 
clinical studies, we explored agreement between proton magnetic resonance spectroscopy 
(
1
H-MRS) and enzymatic assessment of renal triglyceride content (without and with dietary 
intervention). We further studied the correlation between fatty kidney and fatty liver. 
Methods 
Triglyceride content in the renal cortex was measured by 
1
H-MRS on a 7-Tesla scanner in 27 
pigs, among which 15 minipigs had been randomized to a 7-month control diet, cafeteria diet 
(CAF), or CAF with low-dose streptozocin (CAF-S) to induce insulin-independent diabetes. 
Renal biopsies were taken from corresponding MRS-voxel locations. Additionally, liver 
biopsies were taken and triglyceride content in all biopsies was measured by enzymatic assay. 
Results 
Renal triglyceride content measured by 
1
H-MRS and enzymatic assay correlated positively 
(r=0.86, P<0.0001). Compared to control diet-fed minipigs, renal triglyceride content was 
higher in CAF-S fed minipigs (137±51 nmol/mg protein, mean±SEM, P<0.05), but not in 
CAF-fed minipigs (60±10 nmol/mg protein) compared to controls (40±6 nmol/mg protein). 
Triglyceride content in liver and kidney biopsies were strongly correlated (r=0.97, P<0.001).  
Conclusions 
Non-invasive measurement of renal triglyceride content by 
1
H-MRS closely predicts 
triglyceride content as measured enzymatically in biopsies, and fatty kidney appears to 
develop parallel to fatty liver. 
1
H-MRS may be a valuable tool to explore the role of fatty 
kidney in obesity and type 2 diabetic nephropathy in humans in-vivo. 
 
Page 5 of 28 Nephrology Dialysis Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
  
2
Keywords:  
Fatty kidney,  hepatic triglyceride content, obesity, proton magnetic resonance spectroscopy, 
renal triglyceride content, type 2 diabetes mellitus, ectopic fat 
  
 
 Short summary:  
Obesity and type 2 diabetes have been linked to renal triglyceride accumulation (fatty kidney) 
and chronic kidney disease. Current study shows that proton magnetic resonance 
spectroscopy may be a valuable, non-invasive tool to further explore the role of fatty kidney 
in obesity and type 2 diabetic nephropathy in humans in-vivo. 
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Introduction 
Over the past decades, the prevalence of obesity and type 2 diabetes has grown to epidemic 
proportions (1). Obesity, in particular central obesity, is associated with metabolic 
dysfunction, which drives the development of insulin resistance leading to type 2 diabetes 
and ultimately end organ damage. The combination of obesity and type 2 diabetes, also 
referred to as diabesity, is often accompanied by other cardiovascular risk factors, including 
hypertension and dyslipidemia. Common early markers of renal disease like glomerular 
hyperfiltration and increased urinary albumin are more prevalent in both obesity and type 2 
diabetes (2). Furthermore, renal pathology has shown considerable overlap between obesity 
and type 2 diabetes (3).  
 
How (early) diabesity may lead to incipient chronic kidney disease remains to be understood, 
but ectopic lipid accumulation in the kidney (fatty kidney) has gained appreciation as a novel 
potential pathway (2,4-6). Diabesity is associated with lipid accumulation in non-adipose 
tissue such as liver, skeletal muscle, and heart, and this so-called ectopic fat may interfere 
with cellular function in the respective organ (7-10). Notably, obesity and type 2 diabetes 
have been associated with renal lipid accumulation in both human and porcine kidneys with 
differences in anatomical distribution between glomeruli and tubuli, as well as cortex and 
medulla (11,12). Increased renal lipid content has also been linked to functional and 
structural renal hyperfiltration (12), obesity-related glomerulopathy (2), and type 2 diabetic 
nephropathy (13). Various rodent models have shown that intervention in cellular lipid 
pathways attenuated obesity-related glomerulopathy or diet-induced chronic kidney disease 
(14). To date, translation of such experimental evidence to the clinical arena has been 
hampered by lack of a non-invasive diagnostic tool to sequentially monitor renal lipid 
accumulation in obesity and type 2 diabetes mellitus. 
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Proton magnetic resonance spectroscopy (
1
H-MRS) is a non-invasive and reproducible 
technique which has been used successfully to quantify lipid content in heart, liver, and 
muscle (15-17). Recently, feasibility and reproducibility of renal 
1
H-MRS in-vivo was shown 
(18). However, few 
1
H-MRS protocols have been validated against tissue biopsies. 
  
Therefore, we explored the agreement of the non-invasive 
1
H-MRS renal triglyceride 
measurement, using a 7-Tesla Magnetic Resonance (MR) scanner, against a biochemical 
assay (as gold standard) to determine lipid accumulation in of porcine kidneys. Secondly, we 
measured renal triglyceride content after a dietary intervention study in minipigs. We 
investigated the effects of a high-fat, high-cholesterol cafeteria diet with and without low-
dose streptozocin to induce non-insulin dependent diabetes mellitus, compared to standard 
diet on renal and hepatic triglyceride content and distribution.  
 
 
Subjects and Methods 
Group A 
Fourteen left-sided porcine kidneys were harvested from two Dutch pig slaughter lines. The 
kidneys were harvested within 30 minutes of termination to limit warm ischemia time and 
were placed on ice. Kidneys were flushed with University of Wisconsin (UW) fluid and were 
scanned upon arrival. Tissue biopsies were taken from both the upper and lower pole of each 
kidney, immediately after scanning. The biopsy locations were visually matched to the areas 
where the 
1
H-MRS measurements were performed. Biopsies were snap frozen in liquid 
nitrogen and stored at -80°C. 
 
Page 8 of 28Nephrology Dialysis Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
  
5
Group B 
Fifteen Göttingen minipigs (19) were studied after they had been randomized to two different 
diets. The control group received a diet consisting primarily of barley, wheat, and soya bean 
oil. The cafeteria group was fed a cafeteria diet (20), with a high content of lard, fructose, 
sucrose, and added cholesterol. Five of the cafeteria diet fed pigs were additionally treated 
with low-dose streptozocin (STZ) after 5 months. The dose of STZ was individually adjusted 
to induce non-insulin dependent diabetes to model type 2 diabetes. After seven months of 
diet, the pigs were euthanized. Directly after termination, blood was drawn and a liver biopsy 
was taken. The whole study was executed at Ecole Veterinaire D’Alfort, France and was 
approved by the local ethics committee for animal experiments. The same harvesting and 
analyses protocols performed for Group A were followed: left sided kidneys were harvested 
with a maximum of 30 minutes warm ischemia time, kidneys were flushed with UW fluid 
and transported to the hospital in the Netherlands on ice, for subsequent 7-Tesla MR 
scanning. After each MR scan, renal biopsies were taken from the corresponding MRS-voxel 
location of the upper and lower kidney poles. Biopsies were snap-frozen and stored at -80°C. 
For both groups A and B, all kidneys had a maximum cold ischemia time of 20 hours before 
1
H-MRS was performed. 
 
Measurements 
Proton Magnetic Resonance Spectroscopy 
A 7-Tesla Philips Magnetic Resonance Imaging (MRI) scanner (Philips Healthcare, Best, The 
Netherlands) was used to measure renal triglyceride content by 
1
H-MRS. A Nova quadrature 
transmit and 32-channel receive head coil (Nova Medical, Wilmington, MA, USA) was used 
for transmission and reception. A survey together with a Dixon water-fat scan was performed 
to position the MRS voxel (10x10x10 mm
3
) within the cortex of the kidney trying to avoid 
Page 9 of 28 Nephrology Dialysis Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
  
6
the medulla as much as possible (21). On the Dixon scan fat image (Figure 1) correct 
placement was confirmed, carefully avoiding extracellular (sinus or perirenal) lipids in the 
voxel. Secondly, measurements were performed in the upper and lower pole of each kidney. 
Stimulated-echo acquisition mode (STEAM) spectra were acquired with an echo time of 8.2 
ms without water suppression (repetition time (TR) 9 s, 3 averages) and with Multiply 
Optimized Insensitive Suppression Train (MOIST) water suppression (TR 3.5 s, 96 averages) 
(22,23). The MRS acquisition had a bandwidth of 3000 Hz and 4096 samples were acquired 
resulting in spectral resolution of 0.73 Hz / sample. All spectra were fitted in the time-domain 
using the Java-based MR User Interface (jMRUI) (24). The advanced method for accurate, 
robust and efficient spectral fitting (AMARES) algorithm was used to fit the resonances to a 
Gaussian line shape. Triglyceride content was calculated as a percentage of the 
(unsuppressed) water peak using the following equation: 
 
 
 
where,  TG = renal triglyceride content [%] 
TG methyl = Area of the methyl resonance at 0.9 ppm [arbitrary unit] 
TG methylene = Area of the methylene resonance at 1.3 ppm [arbitrary unit] 
Water = Area of the water resonance [arb. unit] 
 
Enzymatic measurement of lipids in renal and liver biopsy 
The biopsies from the upper and lower pole of each kidney, as well as the liver biopsies were 
snap-frozen in liquid nitrogen, homogenized, and total lipids were extracted according to a 
modified protocol from Bligh and Dyer (25). Total triglycerides were measured by an 
enzymatic kit (no. 11488872, Roche Diagnostics). The triglyceride content per biopsy was 
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divided by the protein content (nmol triglycerides/mg protein) to correct for the size of the 
biopsy. 
 
Oil Red O staining 
Frozen kidney sections (10-µm thickness) were cut on a Reichert cryostat microtome. Oil 
Red O (ORO) staining was performed by incubation of the slides with an ORO solution (2 
mg/ml in 40% isopropanol). Sections were rinsed with ethanol, covered with Aqua-Mount 
mounting media and digitized with a Philips Ultra-Fast 1.6 RA Scanner (Philips, The 
Netherlands). The ORO positive surface area was measured using the ImageJ (U. S. National 
Institutes of Health, Bethesda, Maryland, USA) on 5 random selected areas of the renal 
cortex, and the percentage of the positive area was calculated. 
 
Other laboratory measurements 
Concentrations of plasma triglycerides and creatinine (both total coefficient of variation 
(CV): 1.0-1.2%, determined by vendor), urinary creatinine (total CV: 0.5-0.7%) and urinary 
protein (total CV: 0.2-0.6%) were measured on a Modular P800 analyzer (Roche, Basel, 
Switzerland). Plasma fructosamine (total CV 1.2-1.5%) was measured using a Cobas 6000 
analyzer (Roche, Basel, Switzerland).  
 
Statistics 
All statistical analyses were performed using SPSS version 22.0 (IBM SPSS Statistics for 
Windows. Armonk, NY: IBM Corp). Plots were created using Graph Pad (Graph Pad 
Software, La Jolla California USA). All but one analysis were performed with the average 
triglyceride content from the upper and lower pole of each kidney. Bland-Altman analysis 
was performed to evaluate the agreement between renal TG content by 
1
H-MRS and renal 
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lipid content by enzymatic essay, after normalization of the data. In one case the triglyceride 
content of a single pole was taken due to a corrupt MRS data file. Agreement between the 
triglyceride measurement techniques was evaluated by linear regression with a 95% 
prediction interval. Group differences between the three experimental groups were analyzed 
using analysis of variance (ANOVA). Least significant difference (LSD) post-hoc tests were 
used in case of a significant difference. Non-normally distributed data were log-transformed 
and checked for normality after transformation. Data are expressed as mean values ± standard 
error of the mean (SEM) and a probability value of 0.05 or less was considered statistically 
significant. 
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Results 
Validation of renal triglyceride quantification by 
1
H-MRS 
Renal triglyceride content was measured in 29 left sided porcine kidneys by 
1
H-MRS and by 
enzymatic assay. Two measurements had to be excluded from further analysis due to a failed 
measurement in the enzymatic assay and one due to a corrupt MRS data file, resulting in a 
total of 27 measurements (n=12 from group A, n=15 from group B). 
 
In group A (slaughter pigs), the mean renal triglyceride content was 0.23±0.03% 
(mean±SEM) as measured by 
1
H-MRS and 111±15 nmol/mg protein as measured by 
enzymatic assay. The mean renal triglyceride content in group B (minipigs) was 0.15±0.03% 
as measured by 
1
H-MRS and 79±20 nmol/mg protein as quantified by enzymatic assay. 
 
Data from groups A and B were pooled and triglyceride content measured by 
1
H-MRS and 
enzymatic assay showed a positive correlation (r=0.86, P<0.0001, Figure 2). The regression 
equation was as follows: triglycerides measured by 
1
H-MRS (%) = 0.03 + 0.0017 x 
triglycerides measured by enzymatic assay (nmol/mg). The triglyceride content for the pooled 
data ranged from 0.06% to 0.8% as measured by 
1
H-MRS and from 30 to 331 nmol/mg 
protein as measured by enzymatic assay.  
The Bland-Altman analysis using the normalized data showed good agreement with a bias of 
0.00 (limits of agreement -0.8; 0.8) for 
1
H-MRS and enzymatic essay measurements of renal 
lipid content over the metabolic spectrum (Figure 2).  
 
Effects of cafeteria diet and streptozocin 
The minipigs were 2.7±0.2 years of age at termination. The pigs in the control group were 
heavier at the start of the study (62.7±3.3 kg, P<0.05) than the pigs in the cafeteria group 
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(51.4±2.0 kg) and cafeteria+STZ group (49.7±2.8 kg). The 7-month cafeteria diet induced a 
significant larger weight gain (39.6±3.6 kg) than the control diet (23.4±3.1 kg, P<0.05) and 
the cafeteria+STZ diet (23.2±5.5 kg, P<0.05, Figure 3). Serum fructosamine was higher in 
the cafeteria+STZ group (358±31 µmol/l, P<0.05), than in the cafeteria (264±6 µmol/l) and 
control group (259±11 mol/l). Serum triglycerides, serum creatinine and urine protein did not 
significantly differ between the groups. 
 
Renal triglyceride content was higher in the cafeteria+STZ group (137±51 nmol/mg protein) 
compared to the control group (40±6 nmol/mg protein, P<0.05) (Figure 3). Renal triglyceride 
content of the cafeteria diet group (60±10 nmol/mg protein) was not significantly different 
from the control group (Figure 3). Renal TG content measured by proton MR spectroscopy, 
showed a similar trend between the groups, however this was not statistically significant. 
Similarly, hepatic triglyceride content after the 7-month diet was higher in the cafeteria+STZ 
group (417±157 nmol/mg protein) compared to the control group (67±11 nmol/mg protein, 
P<0.05). The cafeteria group (141±49 nmol/mg protein) had a trend towards higher hepatic 
triglyceride content than the control group, but this was not significantly different (Figure 3). 
We observed a significant correlation between renal and hepatic triglyceride content 
measured by enzymatic assay (n=14, r=0.97, P<0.001, Figure 4).  
  
Lipid distribution  
We also assessed lipid localization by Oil Red O staining. The lipid content was very low in 
biopsies of the control diet group (percentage staining: 0.2±0.0%), and markedly higher in 
those of the cafeteria group (3.7±1.9%, P<0.05 versus control diet) and cafeteria+STZ group 
(9.6±6.3%, P<0.05 versus control diet). There was pronounced lipid accumulation in the 
tubuli and to a lesser extent Oil Red O staining was visible in the glomeruli (Figure 5). 
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Discussion 
The merit of clinical 
1
H-MRS to investigate the role of ectopic lipid accumulation has been 
clearly established for other organs such as liver, muscle, and heart (17, 26,27). In fact, the 
development of 
1
H-MRS of the heart has led to a better understanding of factors influencing 
myocardial triglyceride accumulation in relation to cardiac function in both health and 
diabesity (9,17). Our present study is one of the first to explore 
1
H-MRS as a noninvasive tool 
to study fatty kidney in diabesity and to study agreement with tissue biopsies. 
 
Thus far, only few studies reported on 
1
H-MRS of the kidney, most likely owing to technical 
difficulties to develop and apply this technique reliably to the kidney for several reasons. 
Firstly, adjustment for respiratory motion and carefully avoiding contamination by perirenal 
and sinus fat is necessary to obtain reliable measurements from the kidney cortex only and 
not surrounding structures. Secondly, kidney tissue is not homogenous with substantial 
anatomical and functional variation between cortex and medulla as well as glomeruli and 
tubuli. Lastly, due to the limited space in the kidney cortex, the volume of the measured 
voxel has to be small, resulting in a much lower signal-to-noise-ratio compared to e.g. heart 
and liver. 
  
This notwithstanding, we previously reported a feasibility and reproducibility study of renal 
1
H-MRS in healthy (non-obese) volunteers in-vivo, but variation was apparent even in this 
relative homogenous group of subjects (18).  Consequently, we aimed to improve our 
knowledge on triglyceride distribution across the metabolic spectrum of diabesity and across 
kidney anatomy with regard to voxel placement and data acquisition. Also, few spectroscopy 
protocols underwent validation and testing against invasive, gold standard assessment of 
triglycerides. Because of the impossibility to obtain enough discarded kidneys from obese 
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and type 2 diabetic postmortem kidney donors to perform a validation study (those kidneys 
are often not offered for transplantation), we turned to similar sized porcine kidneys to test 
our clinical 
1
H-MRS protocol. This study in porcine kidneys shows that 
1
H-MRS closely 
predicts the triglyceride content as measured by enzymatic assay of kidney biopsies (gold 
standard) and therefore it may also be a valuable tool to study fatty kidney in humans.  
 
To evaluate the renal triglyceride content over the metabolic spectrum in conjunction with the 
hepatic triglyceride content, we used minipigs fed a high fat, high cholesterol diet to develop 
a metabolic syndrome phenotype including high amounts of visceral fat and insulin resistance 
(19). Because those pigs have a large pancreatic beta cell capacity, it takes a very long time to 
develop type 2 diabetes. Therefore the pigs were individually treated with a low dose of STZ 
to damage a part of the pancreatic beta cell capacity, to create non-insulin dependent diabetes 
that reflects type 2 diabetes. Using this model, we showed that renal triglyceride content 
increased over the metabolic spectrum in conjunction with hepatic triglycerides. 
 
We observed a trend to an increase in both renal and hepatic triglyceride content in the 
cafeteria diet only group, however this was not significant. Previous studies have shown 
correlation between increased bodyweight and increased hepatic and renal triglyceride 
content in both animals and humans (11,12,28,29). As our study was exploratory and the 
animal groups small, the study may have been underpowered to detect a significant difference 
between the control and cafeteria group. One possible confounder in this study is the 
difference in baseline weight of the minipigs, as controls were significantly heavier than the 
pigs in the intervention groups. 
 
Page 16 of 28Nephrology Dialysis Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
  
13
Interestingly, pigs in the cafeteria+STZ group, albeit that they had a lower baseline weight 
and equal increase in body weight during the study, did have increased renal triglyceride 
content compared to the controls. In diabetes, the increase in inflammation or chronic kidney 
disease might lead to additional triglyceride redistribution into organs beyond mere obesity 
and thus accentuate the findings (2). We found a strong positive correlation between renal 
and hepatic triglyceride content. A study in mice has shown that from a certain bodyweight, 
the expandability of white adipose tissue becomes limited and fat starts to rapidly accumulate 
ectopically within e.g. the liver (29). It is likely that a similar mechanism may underlie renal 
triglyceride accumulation, which needs to be explored in future studies. 
 
By using Oil Red O staining, we observed similar trends, with increasing triglyceride content 
in the cafeteria group and even more in the cafeteria+STZ group. We found that renal 
triglyceride accumulation was most prominent in renal tubuli, albeit some triglyceride 
staining was also observed in the glomeruli. This is in accordance with a recent study of 
human nephrectomies, where triglyceride droplets were predominantly found in tubular cells 
and to a lesser extent in glomeruli (11). Future studies should focus on even better 
understanding of how triglyceride accumulation may lead to chronic kidney disease in 
diabesity and whether this process can be reversed.  
 
Conclusion 
Non-invasive measurement of renal triglyceride content by 
1
H-MRS closely predicts the 
triglyceride content as measured enzymatically in biopsies. Renal triglyceride content 
increases over the metabolic spectrum of diabesity and in the current study fatty kidney 
develops in parallel with fatty liver. Proton magnetic resonance spectroscopy seems suitable 
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to explore the role of fatty kidney in obesity and type 2 diabetic nephropathy in humans in-
vivo.  
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Figure legends 
  
 
Figure 1  
Placement of the voxel (black box) in the kidney cortex on a transverse and coronal survey 
(A) and Dixon fat image (B). Below the surveys two spectra acquired from the kidney cortex 
of two different kidneys. Spectra have been selected to show an example of low and high 
renal triglyceride (TG) content and have been scaled to the water signal to be able to visually 
compare the two. For quantification TG content the CH2n (1.3 ppm) and the CH3 (0.9 ppm) 
resonances are used. Other visible resonances in the spectra are CH2CH2COO marked with 
number 1 at 1.5 ppm, CHCH2=CHCH2 marked with number 2 at 2 ppm, and CH2COO 
marked with number 3 at 2.2 ppm and a trimethylamine (TMA) resonance at 3.2 ppm. 
 
Figure 2  
Correlation (left) and Bland-Altman difference-average plot (right) of renal triglyceride (TG) 
content measured by 
1
H-MRS and enzymatic assay in biopsies, using pooled data from both 
study A (12 slaughter pigs) and study B (15 minipigs) showing a positive correlation (r=0.86, 
P<0.0001).  
 
Figure 3 
Weight gain (A), renal triglyceride (TG) content measured by proton magnetic resonance 
spectroscopy (
1
H-MRS, B), renal TG content from renal biopsy by enzymatic assay (C), 
hepatic TG content from liver biopsy by enzymatic assay (D) after 7 months of control diet, 
cafeteria diet or cafeteria diet with streptozocin (STZ). Data are represented as mean±SEM 
(n=15 for renal triglycerides, n=14 for hepatic triglycerides). *P<0.05 
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Figure 4 
Correlation between renal and hepatic triglyceride (TG) content after 7 months of diet, 
measured by enzymatic assay in biopsies (n=14). 
 
Figure 5 
Three representative examples of Oil Red O staining for lipids in kidney biopsies from 
minipigs on a 7 months control (A), cafeteria (B) or cafeteria with streptozocin (C) diet. 
Percentage of biopsy with Oil Red O staining in the three diet groups (mean±SEM, n=5 per 
group). *P<0.05 compared to the control diet. 
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Figure 1  
Placement of the voxel (black box) in the kidney cortex on a transverse and coronal survey (A) and Dixon 
fat image (B). Below the surveys two spectra acquired from the kidney cortex of two different kidneys. 
Spectra have been selected to show an example of low and high renal triglyceride (TG) content and have 
been scaled to the water signal to be able to visually compare the two. For quantification TG content the 
CH2n (1.3 ppm) and the CH3 (0.9 ppm) resonances are used. Other visible resonances in the spectra are 
CH2CH2COO marked with number 1 at 1.5 ppm, CHCH2=CHCH2 marked with number 2 at 2 ppm, and 
CH2COO marked with number 3 at 2.2 ppm and a trimethylamine (TMA) resonance at 3.2 ppm.  
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Figure 2  
Correlation (left) and Bland-Altman difference-average plot (right) of renal triglyceride (TG) content 
measured by 1H-MRS and enzymatic assay in biopsies, using pooled data from both study A (12 slaughter 
pigs) and study B (15 minipigs) showing a positive correlation (r=0.86, P<0.0001).  
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Figure 3  
Weight gain (A), renal triglyceride (TG) content measured by proton magnetic resonance spectroscopy (1H-
MRS, B), renal TG content from renal biopsy by enzymatic assay (C), hepatic TG content from liver biopsy 
by enzymatic assay (D) after 7 months of control diet, cafeteria diet or cafeteria diet with streptozocin 
(STZ). Data are represented as mean±SEM (n=15 for renal triglycerides, n=14 for hepatic triglycerides). 
*P<0.05  
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Figure 4  
Correlation between renal and hepatic triglyceride (TG) content after 7 months of diet, measured by 
enzymatic assay in biopsies (n=14).  
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Figure 5  
Three representative examples of Oil Red O staining for lipids in kidney biopsies from minipigs on a 7 
months control (A), cafeteria (B) or cafeteria with streptozocin (C) diet. Percentage of biopsy with Oil Red O 
staining in the three diet groups (mean±SEM, n=5 per group). *P<0.05 compared to the control diet.  
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